CIM
NVO

CIM Investment Management’s Novo Nordisk NVO Stock Holding History

CIM Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,790
Closed -$287K – 357
2016
Q3 		$287K Buy
+13,790
New +$342K 0.11% 253
2014
Q2 		– Sell
-15,290
Closed -$349K – 202
2014
Q1 		$349K Buy
+15,290
New +$326K 0.16% 147

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

CIM Investment Management's NVO Position: Q4 2016 in Review

CIM Investment Management sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 13,790 shares — an estimated $287K sold.

CIM Investment Management first reported a position in NVO in Q1 2014 and held it in 2 quarters. The position peaked at $349K in Q1 2014. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • CIM Investment Management reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • CIM Investment Management sold 13,790 Novo Nordisk shares in Q4 2016, an estimated $287K.
  • CIM Investment Management first reported a position in Novo Nordisk in Q1 2014 and held it in 2 quarters.
  • CIM Investment Management's Novo Nordisk position peaked at $349K in Q1 2014.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on CIM Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.